David A. Broecker was the CEO of Alkermes Inc., a biopharmaceutical company, from 2007 to 2009. He stepped up from being the President and COO, showing a clear career progression within the company. Before joining Alkermes, he worked at Eli...

David A. Broecker was the CEO of Alkermes Inc., a biopharmaceutical company, from 2007 to 2009. He stepped up from being the President and COO, showing a clear career progression within the company. Before joining Alkermes, he worked at Eli Lilly for nearly 16 years, managing one of their largest facilities in Ireland and holding various key positions in Europe and the U.S. Broecker played a crucial role in the commercial success of VIVITROL, a medication for addiction. Interestingly, he had a significant salary of over $1.6 million in 2009, which included a notable severance package after he left. His unique combination of operational experience and leadership in the pharmaceutical industry highlights his influence on Alkermes during a period of growth and change, positioning the company for future endeavors.